GeneDx Holdings Corp (WGS)
22.36
-1.66
(-6.91%)
USD |
NASDAQ |
May 17, 16:00
22.36
0.00 (0.00%)
After-Hours: 20:00
GeneDx Holdings Cash and Short Term Investments (Quarterly): 112.91M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 112.91M |
| December 31, 2023 | 130.15M |
| September 30, 2023 | 114.30M |
| June 30, 2023 | 156.66M |
| March 31, 2023 | 201.90M |
| December 31, 2022 | 123.93M |
| Date | Value |
|---|---|
| September 30, 2022 | 191.36M |
| June 30, 2022 | 284.65M |
| March 31, 2022 | 315.00M |
| December 31, 2021 | 400.57M |
| September 30, 2021 | 461.28M |
| December 31, 2020 | 108.13M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
108.13M
Minimum
Dec 2020
461.28M
Maximum
Sep 2021
216.74M
Average
174.01M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| American Well Corp | 308.60M |
| GoodRx Holdings Inc | 533.30M |
| Privia Health Group Inc | 351.14M |
| Doximity Inc | 762.90M |
| GE HealthCare Technologies Inc | 2.551B |